Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9760
+0.0060 (0.62%)
Jul 28, 2026, 4:04 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 42.16 million as of July 28, 2026. Its market cap has increased by 60.43% in one year.
Market Cap
42.16M
Enterprise Value
43.03M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
ChartMarket Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 42.16M, a decrease of -87.10%. That is a compound annual growth rate of -28.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 42.16M | -34.05% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 115.33B |
| Coloplast | 90.88B |
| Demant | 57.70B |
| Gubra | 5.78B |
| BioPorto | 581.75M |
| Pharma Equity Group | 103.36M |
| ViroGates | 88.64M |